Skip to main content
. 2021 Nov 4;11:726239. doi: 10.3389/fonc.2021.726239

Table 2.

Subgroup analysis for prospective cohort (our center vs. external centers).

Variables Levels Total Our center External centers Pvalue1
Overall MVI− 290 (58.5%) 192 (50.3%) 98 (86.0%) <0.001
MVI+ 206 (41.5%) 190 (49.7%) 16 (14.0%)
Tumor Size 1.0–3.0 cm MVI− 79 (74.5%) 56 (69.1%) 23 (92.0%) 0.022
MVI+ 27 (25.5%) 25 (30.9%) 2 (8.0%)
3.0–5.0 cm MVI− 99 (68.8%) 70 (61.4%) 29 (96.7%) <0.001
MVI+ 45 (31.3%) 44 (38.6%) 1 (3.3%)
≥5.0 cm MVI− 112 (45.5%) 66 (35.3%) 46 (78.0%) <0.001
MVI+ 134 (54.5%) 121 (64.7%) 13 (22.0%)
Tumor Number 1 MVI− 253 (61.7%) 160 (52.6%) 93 (87.7%) <0.001
MVI+ 157 (38.3%) 144 (47.4%) 13 (12.3%)
2 MVI− 23 (45.1%) 19 (42.2%) 4 (66.7%) 0.390
MVI+ 28 (54.9%) 26 (57.8%) 2 (33.3%)
3 MVI− 4 (40.0%) 4 (40.0%) 0 Not Applicable
MVI+ 6 (60.0%) 6 (60.0%) 0
>3 MVI− 10 (40.0%) 9 (39.1%) 1 (50.0%) 1.000
MVI+ 15 (60.0%) 14 (60.9%) 1 (50.0%)
BCLC Staging 0A MVI− 257 (61.2%) 164 (52.2%) 93 (87.7%) <0.001
MVI+ 163 (38.8%) 150 (47.8%) 13 (12.3%)
B MVI− 33 (43.4%) 28 (41.2%) 5 (62.5%) 0.283
MVI+ 43 (56.6%) 40 (58.8%) 3 (37.5%)
AFP Level ≦20 MVI− 156 (69.6%) 114 (63.7%) 42 (93.3%) <0.001
MVI+ 68 (30.4%) 65 (36.3%) 3 (6.7%)
20–400 MVI− 69 (54.3%) 44 (45.4%) 25 (83.3%) <0.001
MVI+ 58 (45.7%) 53 (54.6%) 5 (16.7%)
≧400 MVI− 65 (44.8%) 34 (32.1%) 31 (79.5%) <0.001
MVI+ 80 (55.2%) 72 (67.9%) 8 (20.5%)

MVI, microvascular invasion; AFP, alpha fetoprotein. 1principles for selecting P values and statistics: (1) For continuous variables, if they met normal distribution, we used T-test results; otherwise, we used Wilcoxon results. (2) For categorical variables, we used chi-square test or Fisher exact probability method. 2. Data description method: (1) For continuous variables, if they satisfied normal distribution, we selected the mean (standard deviation); otherwise, we selected the median (interquartile range). (2) For categorical variables, they were described as N (%) under different categories.